SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+4.69%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$761M
AUM Growth
+$761M
(+53%)
Cap. Flow
+$334M
Cap. Flow
% of AUM
43.93%
Top 10 Holdings %
Top 10 Hldgs %
72.58%
Holding
49
New
7
Increased
2
Reduced
11
Closed
1
Top Buys
| 1 |
LENZ
LENZ Therapeutics
LENZ
|
$228M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$34.1M |
| 3 |
Recursion Pharmaceuticals
RXRX
|
$28.3M |
| 4 |
RAIN
Rain Oncology Inc. Common Stock
RAIN
|
$25.4M |
| 5 |
Janux Therapeutics
JANX
|
$15.2M |
Top Sells
| 1 |
CureVac
CVAC
|
$8.72M |
| 2 |
Aclaris Therapeutics
ACRS
|
$4.01M |
| 3 |
VistaGen Therapeutics
VTGN
|
$3.46M |
| 4 |
Terns Pharmaceuticals
TERN
|
$2.56M |
| 5 |
KRON
Kronos Bio
KRON
|
$2.11M |
Sector Composition
| 1 | Healthcare | 98.51% |
| 2 | Financials | 1.08% |
